Rate of Corneal Grafting Post-Glaucoma Drainage Device Use in Pediatric and Adult Patients.
Armin Garmany, Catherine Knier, Felix Kung, Camilo Mejia, Jason Sargent, Dogahe Sepideh Jamali, Nouran Sabbagh, David Hodge, Cheryl L Khanna
Summary
Adult patients were more likely to receive a corneal graft after GDD placement.
Abstract
PRCIS
Kaplan-Meier analysis was used to compare the rate of corneal grafting after glaucoma drainage device (GDD) placement in pediatric and adult patients. Adults were at an increased risk of receiving a corneal graft after device placement.
PURPOSE
The goal of this study was to compare the rate of corneal graft implantation after GDD placement in pediatric and adult patients.
PATIENTS
Patients receiving a GDD between January 1, 1985 and December 31, 2017 were selected from the medical records. Patients receiving their first device while <18 years of age were considered children for the extent of the study.
METHODS
We compared the rate of receiving a corneal graft after GDD implantation using Kaplan-Meier analysis. Baseline patient characteristics and surgical characteristics were compared using a generalized estimating equation.
RESULTS
Corneal grafting occurred in 8.6% of adults and 4.7% of children from the original cohort. The rate of receiving a corneal graft at 5, 10, and 15 years was 9.4%, 16.8%, 39.4% and 1.6%, 1.6%, 12.5% for adults and children, respectively. However, certain characteristics were different between the 2 groups.
CONCLUSION
Adult patients were more likely to receive a corneal graft after GDD placement. However, pediatric and adult patients differed in the prevalence of preexisting corneal disease, glaucoma type, GDD type used, and types of previous surgeries. Elucidation of the impact of these factors on corneal graft rate requires a larger cohort size.
More by Armin Garmany
View full profile →Need for Additional Glaucoma Surgery and Complications Following Glaucoma Drainage Device Surgery.
Analysis of Standard Automated Visual Field Tests in Glaucoma and the Role of Facial Contour.
3D facial reconstruction refines 60-4 visual field assessment.
Top Research in Epidemiology & Genetics
Browse all →The Risks and Benefits of Myopia Control.
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Neuroprotective strategies for retinal disease.
Discussion
Comments and discussion will appear here in a future update.